Price
With this share price and small float I'm surprised a big pharma doesn't try to buy this company. What a steal that would be. Especially when there so close to their first approved drug. Anyhow I'm shocked that the support is not there. We could be looking at a forty to fifty dollar stock in the near future. I'm guessing most people don't understand the high probability this has to getting passed.